Patent · US Active

Use of ginsenoside M1 for manufacturing medicament for treating oral cancer

US11524021B2 · kind B2 · utility

0Cited by
1References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 17, 2019
Grant dateDec 13, 2022
Priority date—
Expiry dateApr 17, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J17/005
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A use of ginsenoside M1 for manufacturing a medicament for treating oral cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.